MedTrace Logo

Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis

NCT01175538 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2010-08-05

No results posted yet for this study

Summary

To assess the effects of lactulose for the prevention of first episode of altered sensorium (hepatic encephalopathy, primary prophylaxis) in patients with cirrhosis.

Conditions

  • Hepatic Encephalopathy

Interventions

DRUG

Lactulose

In the Gp-L group, patients will receive 30-60 ml of lactulose in 2 or 3 divided doses so that patient passes 2-3 semisoft stools per day

DRUG

Lactulose

lactulose will be used in 30-60ml/day

Sponsors & Collaborators

  • Govind Ballabh Pant Hospital

    lead OTHER_GOV

Principal Investigators

  • Barjesh C Sharma, MD,DM · G B Pant Hospital New Delhi 110002

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2010-06-30
Completion
2010-09-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01175538 on ClinicalTrials.gov